Clinical trials for breast implants are research studies where medical device manufacturers and medical centers work together to test new implant designs, materials, or surgical techniques before they become widely available to the public. These trials serve a specific purpose in the medical device approval process: they generate real-world data about how implants perform, how long they last, and what complications or side effects might occur over time.
Learn About Paying Your FGUA Bill Online →
The U.S. Food and Drug Administration (FDA) requires manufacturers to conduct clinical trials for breast implants before approving them for general use. This requirement exists because breast implants are considered Class III medical devices, which means they carry potential risks that need careful monitoring. Unlike a medication you take once and your body processes, breast implants remain in your body for years, so researchers need to track outcomes over extended periods—sometimes five, ten, or even twenty years.
Breast implant clinical trials typically involve hundreds of participants across multiple surgical centers. Participants receive implants as part of the study protocol, and then researchers follow up with them through examinations, imaging tests, and questionnaires at regular intervals. Some trials focus on silicone gel implants, others on saline implants, and newer trials may examine alternative materials or shapes designed to reduce certain complications.
The data collected from these trials becomes the scientific foundation for FDA approval decisions and helps surgeons understand which implants work best for different patient situations. Without clinical trials, there would be no structured way to know whether a new implant design truly performs better than existing options or whether it introduces new problems that weren't apparent during initial laboratory testing.
Takeaway: Clinical trials are how the medical system gathers real evidence about implant safety and performance. Understanding their purpose helps you see why they're structured the way they are and what information researchers are trying to collect.
The FDA uses different approval pathways depending on whether a breast implant is entirely new or a modification of an existing design. This matters because it determines whether a clinical trial is required and how large that trial needs to be.
Free Guide to Pay by Plate Illinois Billing →
For implants that are substantially similar to devices already on the market, manufacturers may pursue something called the 510(k) pathway, which doesn't always require a full clinical trial. However, for new implant designs or materials that differ significantly from existing products, the FDA requires a Premarket Approval (PMA) application. This is where clinical trials become mandatory. A PMA clinical trial typically involves 300 to 500 participants across 50 to 100 different surgical centers. These trials generally last several years, with follow-up periods extending well beyond the initial implantation.
The FDA doesn't run the trials themselves—manufacturers and contract research organizations organize and oversee them. However, the FDA reviews trial protocols before they begin to ensure they're designed properly and protect participant safety. The agency also monitors safety data throughout the trial and can halt a study if serious problems emerge.
In 2018, the FDA released updated guidance for breast implant clinical trials, emphasizing the need for longer follow-up periods and more detailed tracking of complications like capsular contracture (scar tissue tightening around the implant), implant rupture, and certain rare conditions. This guidance shaped how newer trials are being designed, requiring more rigorous data collection methods than older studies used.
Understanding where a particular implant sits in this approval process tells you something important: whether its safety and performance have been tested through a formal clinical trial or whether it's considered similar enough to existing implants that a smaller study was conducted. Both categories are FDA-regulated, but the level of real-world testing differs significantly.
Takeaway: The FDA approval pathway determines whether a clinical trial happens and how thorough it is. Knowing this helps you understand why some implants have more published research behind them than others.
Breast implant clinical trials aren't all the same. Researchers conduct different types of studies depending on what questions they're trying to answer and which implants or techniques they're examining.
Free Guide to Mold Removal Methods for Walls →
Some trials focus on safety and effectiveness of a single implant type—for instance, a new silicone gel formulation designed to reduce the risk of rupture. These studies track participants over time, measuring implant integrity through physical exams and imaging (usually MRI or ultrasound), and documenting any complications. Researchers also collect information about patient satisfaction, aesthetic outcomes, and quality of life measures.
Other trials compare two or more implant types side-by-side to see which performs better. For example, a comparative trial might enroll some participants with implant type A and others with implant type B, then follow both groups using identical measurement methods to see whether one group has fewer complications or higher satisfaction rates.
Some specialized trials examine specific populations—such as women undergoing breast reconstruction after cancer surgery versus those having cosmetic augmentation. The body's response to implants can differ between these groups, so researchers sometimes run separate trials to understand these differences.
Within all these trial types, researchers measure several standard outcomes: implant rupture rates (how often the outer shell fails), capsular contracture rates (hardening and tightening of scar tissue around the implant), infection rates, reoperation rates (how often people need surgery to replace or remove the implant), and various patient-reported measures about comfort, appearance, and satisfaction. Some newer trials also track rare outcomes like textured implant-associated anaplastic large cell lymphoma (BIA-ALCL), a specific type of cancer associated with certain implant surfaces.
The duration of these trials varies. Older trials sometimes followed participants for just a few years, but current FDA guidance expects manufacturers to track participants for at least 10 years, with some trials continuing for 20 years or longer to capture delayed complications.
Takeaway: Clinical trials measure multiple outcomes over years, not just whether the implant stays intact. Knowing what researchers track helps you understand what evidence exists about different implant options.
If you're interested in learning about breast implant clinical trials—whether to understand what research exists or to explore whether you might participate—there are several reliable places to find this information.
How to Delete Your Fitbit Account Guide →
ClinicalTrials.gov is a free, publicly searchable database maintained by the National Library of Medicine. You can search for breast implant trials by entering terms like "breast implant," "silicone implant," or "breast augmentation." The database shows you trial status (recruiting, active but not recruiting, completed, or suspended), location, a description of what the trial involves, basic eligibility criteria, and contact information for the research site. The search results show both trials currently enrolling participants and those that have finished but haven't yet published their results.
The FDA's website contains information about approved breast implants and links to trial data for devices that went through the PMA process. When you look up a specific implant by brand name (like Mentor, Allergan, or Sientra), you can often find links to the clinical trial data that supported its approval.
Manufacturers' websites sometimes provide information about ongoing trials for their implants. If a company is running a study, their site may list participating centers and basic information about the study.
Medical centers that perform a lot of breast surgery sometimes post information about trials they're participating in, either on their surgical department websites or through dedicated research websites. Academic medical centers in particular often have several active trials running simultaneously.
When you're reviewing trial information, pay attention to these details: the trial's current status and location, what specific implant or technique it's studying, how many participants are involved, how long the study lasts, and what the follow-up schedule involves. Some trials require frequent office visits and imaging tests, while others have minimal follow-up requirements.
Takeaway: ClinicalTrials.gov is your starting point for finding factual information about breast implant studies. Knowing how to search this database and what information to look for gives you direct access to official research information.
Clinical trials involving surgical procedures and implanted devices have structured safety oversight that differs from standard medical care. Understanding how this works helps you see what protections are in place if someone decides to participate in a trial.
Learn How to Grow Sweet Corn at Home →
Every clinical trial has an Institutional Review Board (IRB), which is an independent committee that
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.